 COPENHAGEN, Denmark, April 6, 2021 Bavarian Nordic AS OMX: BAVA, OTC: BVNRY announced today that the Company has received a new supply order from Janssen Pharmaceutica NV, part of the Janssen Pharmaceutical Companies of Johnson Johnson, valued at approximately USD 28 million. 